A Study of Ralinepag in Healthy Chinese Adult Subjects

Clinical trial NCT04613999 · COMPLETED

Trial details

NCT number: NCT04613999
Sponsor: Everstar Medicines (Shanghai) Limited
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteer Pharmacokinetic Study

Start date: 2020-10-09
Primary completion: 2020-11-09
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.